[HTML][HTML] The rationale for angiotensin receptor neprilysin inhibitors in a multi-targeted therapeutic approach to COVID-19

A Bellis, C Mauro, E Barbato, B Trimarco… - International Journal of …, 2020 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
determines the angiotensin converting enzyme 2 (ACE2) down-regulation and related …

[PDF][PDF] The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19

A Bellis, C Mauro, E Barbato, B Trimarco… - Int. J. Mol. Sci, 2020 - scienceopen.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
determines the angiotensin converting enzyme 2 (ACE2) down-regulation and related …

The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19

A Bellis, C Mauro, E Barbato, B Trimarco… - Int. J. Mol …, 2020 - search.proquest.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
determines the angiotensin converting enzyme 2 (ACE2) down-regulation and related …

The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19.

A Bellis, C Mauro, E Barbato, B Trimarco… - International Journal of …, 2020 - europepmc.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
determines the angiotensin converting enzyme 2 (ACE2) down-regulation and related …

The rationale for angiotensin receptor neprilysin inhibitors in a multi-targeted therapeutic approach to COVID-19

A Bellis, C Mauro, E Barbato, B Trimarco… - INTERNATIONAL …, 2020 - iris.uniroma1.it
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
determines the angiotensin converting enzyme 2 (ACE2) down-regulation and related …

The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19

A Bellis, C Mauro, E Barbato, B Trimarco, C Morisco - 2020 - agris.fao.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
determines the angiotensin converting enzyme 2 (ACE2) down-regulation and related …

The rationale for angiotensin receptor neprilysin inhibitors in a multi-targeted therapeutic approach to COVID-19

A Bellis, C Mauro, E Barbato, B Trimarco… - INTERNATIONAL …, 2020 - iris.unina.it
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
determines the angiotensin converting enzyme 2 (ACE2) down-regulation and related …

[PDF][PDF] The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19

A Bellis, C Mauro, E Barbato, B Trimarco… - Int. J. Mol …, 2020 - pdfs.semanticscholar.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
determines the angiotensin converting enzyme 2 (ACE2) down-regulation and related …

[HTML][HTML] The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19

A Bellis, C Mauro, E Barbato, B Trimarco… - International Journal of …, 2020 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
determines the angiotensin converting enzyme 2 (ACE2) down-regulation and related …

The rationale for angiotensin receptor neprilysin inhibitors in a multi-targeted therapeutic approach to COVID-19.

A Bellis, C Mauro, E Barbato, B Trimarco, C Morisco - 2020 - cabidigitallibrary.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
determines the angiotensin converting enzyme 2 (ACE2) down-regulation and related …